Matt Tremblay, Blackbird Laboratories CEO
November 7, 2023 06:00 AM EST
Financing
Startups

Ex­clu­sive: With back­ing of Ravens own­er, Black­bird launch­es with $100M to boost Bal­ti­more’s biotech scene

Andrew Dunn

Senior Biopharma Correspondent

A life sci­ences ac­cel­er­a­tor called Black­bird Lab­o­ra­to­ries has $100 mil­lion to spend to turn Bal­ti­more in­to a biotech hub.

Black­bird was found­ed at the start …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times